NIGHT HEMODYNAMIC DISORDER RISK FACTORS AND MARKERS FOR PATIENT-SPECIFIC APPROACH TO CARDIOVASCULAR DISEASE PREVENTION IN CHILDREN

Background:  High mortality rates of cardiovascular disease request research revealing risk factors and early markers of cardiovascular dysfunction in children with chronic pathology.

Objective:  to reveal the risk factors and early markers of night hemodynamic disorders for the development of personalized cardiovascular disease prevention in children based on the results of the combined daily monitoring of arterial pressure, ECG examination, and analysis of night sleep. Patients and methods:  Parents filled screeningquestionnaire of night sleep before the study onset. Combined monitoring and examination was performed  in 232  children aged 6–17 with different blood pressure disorders using Astrocard НS E2bp (Russia) equipment in the outpatient setting.

Results: 24-hour BP monitoring identified arterial hypotension 3.8 times more often than routine ambulance method. 21% of children or every fifth child with hypotension  had night hypertension  associated  with maximum (93%) pathology  of ENT organs  with nasal obstruction. Differentiation of investigated groups by night PP and DBP show these marks of hemodynamics to be really important at the early period of pathology development in children. 62% of children had QT interval with bad adaptation to RR-interval at night. In the group with high BMI we found 1.6 times more often children with height more than 85th percentile of the norm. These children had night diastolic hypotension  5 times more often, children with obesity didn’t have normal 24-hour  BP dynamics, children with high BMI had longer QT-interval at night.

Conclusions: We demonstrate the necessity of night sleep hemodynamics investigation in children for personalized cardiovascular disorder prevention. Children of early school age suffering from chronic ENT-pathology with nasal obstruction and/or high BMI, with high BMI, and with height ≥85th percentile of gender-age norm have risk of development of cardiovascular diseases.

1. Леонтьева И.В. Атеросклероз, ишемическая болезнь сердца, инфаркт миокарда как педиатрические проблемы: лекция № 29. — М.: Московский научно-исследовательский институт педиатрии и детской хирургии, ДЭМИКОН; 1997. — 60 с. [Leont’eva IV. Ateroskleroz, ishemicheskaya bolezn’ serdtsa, infarkt miokarda kak pediatricheskie problemy: lektsiya № 29. Moscow: Moskovskii nauchno-issledovatel’skii institut pediatrii i detskoi khirurgii, DEMIKON; 1997. 60 p. (In Russ).]

2. Оганов Р.Г. Эпидемиология и профилактика основных сердечно-сосудистых заболеваний // Архив патологии. — 1992. — Т.54. — №4 — С. 13–15. [Oganov RG. Epidemiologiya i profilaktika osnovnykh serdechno-sosudistykh zabolevanii. Arkh Patol. 1992;54(4):13–15. (In Russ).]

3. Баранов А.А. Научные и практические проблемы российской педиатрии на современном этапе // Педиатрия. Журнал им. Г.Н. Сперанского. — 2005. — Т.84. — №3 — С. 4–7. [Baranov AA. Scientific and practical problems of Russian pediatrics today. Pediatria. 2005;84(3):4–7. (In Russ).]

4. Мадаева И.М., Шавырталова О.Н., Долгих В.В. Артериальная гипертензия и нарушения дыхания во время сна в педиатрии: результаты пилотного исследования // Педиатрия. Приложение Consilium Medicum. — 2009. — №2 — С. 28–31. [Madaeva IM, Shavyrtalova ON, Dolgich VV. Arterial hypertension and sleep apnea in pediatrics: results of pilot trial. Pediatriya. Prilozhenie Consilium Medicum. 2009;(2):28–31. (In Russ).]

5. Макаров Л.М. Холтеровское мониторирование. Монография. 4-е изд. — М.: Медпрактика–М; 2017. — 504 с. [Makarov LM. Kholterovskoe monitorirovanie. Monografiya. 4nd ed. Moscow: Medpraktika–M; 2017. 504 p. (In Russ).]

6. Рекомендации по лечению артериальной гипертонии. ESH/ESC 2013 // Российский кардиологический журнал. — 2014. — №1 — С. 7–94. [Rekomendatsii po lecheniyu arterial’noi gipertonii. ESH/ESC 2013. Russian journal of cardiology. 2014;(1):7–94. (In Russ).]

7. Kheirandish-Gozal L, Gozal D, editors. Sleep-disordered breathing in children. A comprehensive clinical guide to evaluation and treatment. Humana Press; 2012. p. 593.

8. Kirk V, Midgley J, Giuffre M, et al. Hypertension and obstructive sleep apnea in Caucasian children. World J Cardiol. 2010;2(8):251–256. doi: 10.4330/wjc.v2.i8.251.

9. Alan H. Sleep-time blood pressure: a validated therapeutic target. J Am Coll Cardiol. 2011;58(11):1174–1175. doi: 10.1016/j.jacc.2011.05.040.

10. Somers VK, White DP, Amin R, et al. Sleep apnea and cardiovascular disease: an American Heart Association/american College Of Cardiology Foundation Scientific Statement from the American Heart Association Council for High Blood Pressure Research Professional Education Committee, Council on Clinical Cardiology, Stroke Council, and Council On Cardiovascular Nursing. In collaboration with the National Heart, Lung, and Blood Institute National Center on Sleep Disorders Research (National Institutes of Health). Circulation. 2008;118(10):1080–1111. doi: 10.1161/CIRCULATIONAHA.

11. Mindell JA, Owens JA. A clinical guide to pediatric sleep: diagnosis and management of sleep problems. 2nd ed. LWW; 2010. p. 232.

12. Lurbe E, Torro I, Aguilar F, et al. Added impact of obesity and insulin resistance in nocturnal blood pressure elevation in children and adolescents. Hypertension. 2008;51(3):635–641. doi: 10.1161/HYPERTENSIONAHA.107.099234.

13. who.int [интернет]. Всемирная организация здравоохранения. Глобальная стратегия по питанию, физической активности и здоровью. Рост масштабов избыточного веса и ожирения среди детей [доступ от 21.03.2017]. [WHО. Global Strategy on Diet, Physical Activity and Health. Childhood overweight and obesity. (In Russ).] Доступ по ссылке http://www.who.int/dietphysicalactivity/childhood/ru.

14. Рогоза А.Н. Суточное мониторирование артериального давления // Сердце. — 2002. — Т.1. — №5 — С. 240–243. [Rogoza AN. Sutochnoe monitorirovanie arterial’nogo davleniya. Serdtse. 2002;1(5):240–243. (In Russ).]

15. Кожевникова О.В. Факторы риска и маркеры ранней диагностики сердечно-сосудистых болезней у детей: Автореф. … дисс. докт. мед. наук. — М.; 2017. — 311 с. [Kozhevnikova OV. Faktory riska i markery rannei diagnostiki serdechno-sosudistykh boleznei u detei. [dissertation abstract] Moscow; 2017. 311 p. (In Russ).]

16. Балабанов А.С., Маянский Н.А. Представление результатов статистического анализа в медицинских публикациях // Вопросы диагностики в педиатрии. — 2012. —Т.4. — №1 — С. 5–12. [Balabanov AS, Mayanskiy NA. Presentation of statistical analysis in the medical publications. Pediatric diagnostics. 2012;4(1):5–12. (In Russ).]

17. Кобалава Ж.Д. Современные проблемы артериальной гипертонии // Артериальная гипертензия. — 2002. — Т.8. — №3 — C. 48. [Kobalava ZhD. Sovremennye problemy arterial’noi gipertonii. Arterial’naya gipertenziya. 2002;8(3):48. (In Russ).]

18. Костюшина И.С., Комарова О.В., Мазо А.М., и др. Роль показателей центральной гемодинамики, толщины комплекса интима-медиа и эндотелиальной дисфункции у детей с ренальной артериальной гипертензией // Педиатрическая фармакология. — 2013. — Т.10. — №3 — C. 32–37. [Kostyushina IS, Komarova OV, Mazo AM, et al. Role of central hemodynamic parameters, intimal medial thickness and endothelial dysfunction in children with renal arterial hypertension. Pediatric pharmacology. 2013;10(3):32–37. (In Russ).] doi: 10.15690/pf.v10i3.695.

19. Eckel RH, Kahn R, Robertson RM, Rizza RA. Preventing cardiovascular disease and diabetes: a call to action from the American Diabetes Association and the American Heart Association. Diabetes Care. 2006;29(7):1697–1699. doi: 10.2337/dc06-9911.